Shorts down to 12.447, down 57,58%, page-4

I’ve been following this company for a long time, and was an investor many years ago. Some in my family remain shareholders today.

I was having a look at the company’s website this morning..

David Stamler has seriously impressive credentials. I hope for shareholders that he can make a positive contribution. The company seems to have been operating at snail’s pace for many years. Hopefully Stamler can change that.

The chairman needs to step up as well. He has plenty of skin in the game - that alone should be enough motivation.

I note the comments about P1 data for PBT434 being ‘potentially clinically significant’. That doesn’t sound very optimistic?

2020 is certainly make or break for Alterity. Hope for all holders it’s a big success.